A detailed history of High Tower Advisors, LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 83,284 shares of CUE stock, worth $83,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,284
Previous 83,284 -0.0%
Holding current value
$83,284
Previous $103,000 38.83%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.24 - $2.18 $7,172 - $12,609
5,784 Added 7.46%
83,284 $103,000
Q1 2024

May 06, 2024

SELL
$1.77 - $3.09 $1,079 - $1,884
-610 Reduced 0.78%
77,500 $146,000
Q3 2023

Nov 08, 2023

BUY
$2.23 - $4.69 $4,460 - $9,380
2,000 Added 2.63%
78,110 $179,000
Q1 2023

May 11, 2023

BUY
$2.41 - $3.74 $183,425 - $284,651
76,110 New
76,110 $271,000

Others Institutions Holding CUE

About Cue Biopharma, Inc.


  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $35.4M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.